JP2001524814A - ２８種類のヒト分泌タンパク質 - Google Patents

２８種類のヒト分泌タンパク質

Info

Publication number
JP2001524814A
JP2001524814A JP53980098A JP53980098A JP2001524814A JP 2001524814 A JP2001524814 A JP 2001524814A JP 53980098 A JP53980098 A JP 53980098A JP 53980098 A JP53980098 A JP 53980098A JP 2001524814 A JP2001524814 A JP 2001524814A
Authority
JP
Japan
Prior art keywords
polypeptide
sequence
polynucleotide
seq
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP53980098A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001524814A5 (https=
Inventor
ルーベン，スティーブン・エム
ローゼン，クレイグ・エイ
リ，イ
ツェン，ツィーツェン
キャウ，フラ
フィッシャー，キャリー・エル
リ，ハオドン
ソペット，ダニエル・アール
ジェンツ，ライナー・エル
ウェイ，イン・フェイ
ムーア，ポール・エイ
ヤング，ポール・イー
グリーン，ジョン・エム
フェリー，アン・エム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of JP2001524814A publication Critical patent/JP2001524814A/ja
Publication of JP2001524814A5 publication Critical patent/JP2001524814A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4718—Cytokine-induced proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP53980098A 1997-03-14 1998-03-12 ２８種類のヒト分泌タンパク質 Withdrawn JP2001524814A (ja)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US4071097P 1997-03-14 1997-03-14
US4076297P 1997-03-14 1997-03-14
US4818997P 1997-05-30 1997-05-30
US5093497P 1997-05-30 1997-05-30
US4810097P 1997-05-30 1997-05-30
US4835797P 1997-05-30 1997-05-30
US4897097P 1997-06-06 1997-06-06
US5776597P 1997-09-05 1997-09-05
US6836897P 1997-12-19 1997-12-19
US60/040,710 1997-12-19
US60/048,100 1997-12-19
US60/048,970 1997-12-19
US60/048,357 1997-12-19
US60/068,368 1997-12-19
US60/048,189 1997-12-19
US60/040,762 1997-12-19
US60/057,765 1997-12-19
US60/050,934 1997-12-19
PCT/US1998/004858 WO1998040483A2 (en) 1997-03-14 1998-03-12 28 human secreted proteins

Publications (2)

Publication Number Publication Date
JP2001524814A true JP2001524814A (ja) 2001-12-04
JP2001524814A5 JP2001524814A5 (https=) 2005-11-10

Family

ID=27578155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53980098A Withdrawn JP2001524814A (ja) 1997-03-14 1998-03-12 ２８種類のヒト分泌タンパク質

Country Status (6)

Country Link
US (1) US6448230B1 (https=)
EP (1) EP0973892A2 (https=)
JP (1) JP2001524814A (https=)
AU (1) AU6552198A (https=)
CA (1) CA2283678A1 (https=)
WO (1) WO1998040483A2 (https=)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014241A2 (en) * 1997-09-17 1999-03-25 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
WO2000015797A2 (en) * 1998-09-17 2000-03-23 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US6951924B2 (en) * 1997-03-14 2005-10-04 Human Genome Sciences, Inc. Antibodies against secreted protein HTEBYII
WO2000075375A1 (en) * 1999-06-07 2000-12-14 Human Genome Sciences, Inc. 26 human secreted proteins
US6919433B2 (en) 1997-03-14 2005-07-19 Human Genome Sciences, Inc. Antibodies to protein HPMBQ91
AU6552198A (en) 1997-03-14 1998-09-29 Human Genome Sciences, Inc. 28 human secreted proteins
EP0892053A3 (en) * 1997-07-14 1999-12-29 Smithkline Beecham Plc production of recombinant HPMBQ91 polypeptide and uses thereof
EP0996857B1 (en) * 1997-07-17 2009-09-09 Ludwig Institute For Cancer Research Cancer associated nucleic acids and polypeptides
US6410708B1 (en) 1997-11-21 2002-06-25 Genentech, Inc. Nucleic acids encoding A-33 related antigen polypeptides
CA2302936A1 (en) * 1997-09-19 1999-04-01 Magainin Pharmaceuticals, Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
US20030054463A1 (en) * 1997-10-24 2003-03-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
US20040141972A1 (en) 1997-11-21 2004-07-22 Genentech, Inc. Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
US7282565B2 (en) 1998-03-20 2007-10-16 Genentech, Inc. PRO362 polypeptides
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
ATE410512T1 (de) * 1997-11-21 2008-10-15 Genentech Inc Plättchen-spezifische antigene und deren pharmazeutische verwendung
US6686147B1 (en) 1998-07-15 2004-02-03 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
EP1124840A4 (en) * 1998-10-28 2002-07-17 Baylor College Medicine GENES AND PROTEINS SPECIFIC TO OVARIES
US7335737B2 (en) 1998-10-28 2008-02-26 Baylor College Of Medicine Ovary-specific genes and proteins
US6995251B1 (en) 1999-10-28 2006-02-07 Baylor Ovary-specific genes and proteins
EP1961813B1 (en) 1998-12-16 2011-08-10 Novartis Vaccines and Diagnostics, Inc. Human cyclin-dependent kinase (hPNQALRE)
US6579715B1 (en) 1999-01-19 2003-06-17 Lexicon Genetics Incorporated Mammalian cortexin-like proteins and polynucleotides encoding the same
AU2757500A (en) * 1999-02-10 2000-08-29 Human Genome Sciences, Inc. 33 human secreted proteins
JP4836329B2 (ja) * 1999-03-11 2011-12-14 メルク セローノ エス．エイ． 血管接着分子およびその機能の調節
WO2000061626A1 (en) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. 49 human secreted proteins
WO2000058357A1 (en) * 1999-03-26 2000-10-05 Human Genome Sciences, Inc. 50 human secreted proteins
WO2000058494A1 (en) * 1999-03-26 2000-10-05 Human Genome Sciences, Inc. 50 human secreted proteins
JP2002538810A (ja) * 1999-03-12 2002-11-19 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ５０個のヒト分泌タンパク質
AU4010400A (en) * 1999-03-18 2000-10-04 Human Genome Sciences, Inc. 27 human secreted proteins
JP2002539816A (ja) * 1999-03-26 2002-11-26 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ５０個のヒト分泌タンパク質
US7129338B1 (en) 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein
EP1514933A1 (en) * 1999-07-08 2005-03-16 Research Association for Biotechnology Secretory protein or membrane protein
CA2382015A1 (en) * 1999-08-17 2001-02-22 Incyte Genomics, Inc. Membrane associated proteins
EP1227149A4 (en) * 1999-10-27 2004-03-31 Takeda Chemical Industries Ltd New protein and its use
WO2001034796A1 (en) * 1999-11-10 2001-05-17 Compugen Ltd. Chordin-like homologs
US7018810B1 (en) 1999-12-07 2006-03-28 Amgen Inc. Chordin-like molecules and uses thereof
US20030068624A1 (en) * 2000-10-26 2003-04-10 Recipon Herve E. Compositions and methods relating to lung specific genes and proteins
US20050123990A1 (en) * 2001-09-26 2005-06-09 Incyte Corporation Membrane associated proteins
JP4360915B2 (ja) 2002-01-07 2009-11-11 ユーロスクリーン・ソシエテ・アノニム Ｇタンパク質共役受容体ｇｐｒ４３のリガンドおよびその使用
AU2003240822A1 (en) 2002-05-30 2003-12-19 Human Genome Sciences, Inc. Antibodies that specifically bind to neurokinin b
US7056685B1 (en) * 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
SG190596A1 (en) 2008-05-06 2013-06-28 Genentech Inc Affinity matured crig variants

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
EP0679716A4 (en) * 1993-11-12 1999-06-09 Kenichi Matsubara GENE SIGNATURE.
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
AU6552198A (en) 1997-03-14 1998-09-29 Human Genome Sciences, Inc. 28 human secreted proteins
CA2338386A1 (en) 1998-08-10 2000-02-24 Incyte Pharmaceuticals, Inc. Proteases and associated proteins

Also Published As

Publication number Publication date
EP0973892A2 (en) 2000-01-26
CA2283678A1 (en) 1998-09-17
WO1998040483A3 (en) 1998-11-19
US6448230B1 (en) 2002-09-10
AU6552198A (en) 1998-09-29
WO1998040483A2 (en) 1998-09-17

Similar Documents

Publication Publication Date Title
JP2001524814A (ja) ２８種類のヒト分泌タンパク質
US7169565B2 (en) Antibodies to HASAV70 polypeptide
JP2002513295A (ja) １２３種類のヒト分泌タンパク質
US20090088555A1 (en) 44 Human Secreted Proteins
US20070248593A1 (en) 32 Human Secreted Proteins
US7906634B2 (en) HEMCM42 nucleic acids
JP2002518010A (ja) ９４個のヒト分泌タンパク質
JP2002533058A (ja) ９７個のヒト分泌タンパク質
JP2002508167A (ja) １１０個のヒト分泌タンパク質
JP2009131263A (ja) ５０個のヒト分泌タンパク質
JP2001521383A (ja) ２０個のヒト分泌タンパク質
JP2002501738A (ja) ６７個のヒト分泌タンパク質
JP2002500035A (ja) ３６個のヒト分泌タンパク質
JP2001514885A (ja) ７０個のヒト分泌タンパク質
JP2003525566A (ja) １２５個のヒト分泌タンパク質
JP2003524366A (ja) ６４個のヒト分泌タンパク質
JP2002514925A (ja) １９個のヒト分泌タンパク質
JP2001519179A (ja) ５３個のヒト分泌タンパク質
JP2003521216A (ja) ９０個のヒト分泌タンパク質
JP2003521865A (ja) １４８個のヒト分泌タンパク質
US20010016647A1 (en) 29 human secreted proteins
JP2003521215A (ja) ８３個のヒト分泌タンパク質
US20050069943A1 (en) 101 human secreted proteins
JP2002504361A (ja) ３６個のヒト分泌タンパク質
JP2002514090A (ja) ８６種類のヒト分泌タンパク質

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050301

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050301

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20060307